Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

HLN.US Logo

HLN.US - Current Price

$9.76

Company Information

▼
Company Name
Haleon plc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
ISIN: US4055521003
CIK: 0001900304
CUSIP: 405552100
Currency: USD
Full Time Employees: 24,561
Phone: 44 1932 959 500
Website: https://www.haleon.com
Fiscal Year End: December
IPO Date: Jul 22, 2022
Description:

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Address:

The Heights, Weybridge, United Kingdom, KT13 0NY

Directors & Officers

▼
Name Title Year Born
Mr. Brian James McNamara CEO & Executive Director 1966
Ms. Dawn Amanda Allen CFO & Director 1968
Ms. Claire Dickson Chief Digital & Technology Officer NA
Ms. Joanne Russell Head of Investor Relations NA
Mr. Adrian Charles Morris General Counsel 1967
Ms. Tamara Rogers Chief Marketing Officer 1970
Ms. Line De Decker Chief Human Resources Officer 1974
Mr. Filippo Lanzi President of EMEA & LatAm NA
Mr. Keith Choy President of Asia Pacific 1969
Ms. Lisa Paley President of North America 1967

Shares Statistics

▼
Shares Outstanding: 4.45B
Shares Float: 8.98B
% Insiders: 1.40%
% Institutions: 1,234.90%
Short % Float: 0.32%

Valuation Metrics

▼
Enterprise Value: $53.62B
Trailing P/E: 21.76
Forward P/E: 18.28

Financial Highlights

▼
Market Cap: $43.60B
EBITDA: $2.63B
P/E Ratio: $21.76
PEG Ratio: $2.86
Book Value: $2.36
Dividend/Share: $0.07
Dividend Yield: 0.69%
Earnings/Share: $0.45
Profit Margin: 13.81%
Operating Margin: 22.21%
ROA (TTM): 4.61%
ROE (TTM): 9.38%
Revenue (TTM): $11.02B
Revenue/Share (TTM): $2.43
Earnings Growth (YOY): 34.80%
Revenue Growth (YOY): -1.30%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 N/A 0.11 N/A N/A
Sep 30, 2025 0.12 0.13 N/A -816.81%
Jun 30, 2025 0.09 0.11 N/A -1,557.22%
Mar 31, 2025 0.13 0.00 N/A N/A
Dec 31, 2024 0.03 0.10 N/A -7,101.45%
Sep 30, 2024 0.12 0.11 N/A 909.09%
Jun 30, 2024 0.10 0.09 N/A 1,111.11%
Mar 31, 2024 10.34 8.81 N/A 1,736.66%
Dec 31, 2023 0.10 0.13 N/A -2,307.69%
Sep 30, 2023 0.11 0.12 N/A -833.33%
Jun 30, 2023 0.11 0.10 N/A 1,000.00%
Mar 31, 2023 0.11 0.13 N/A -1,538.46%
Dec 31, 2022 0.11 0.11 N/A 363.64%
Sep 30, 2022 0.09 0.11 N/A -2,018.18%
Jun 30, 2022 0.05 0.08 N/A -4,087.50%
Mar 31, 2022 0.00 0.00 N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $2.20B $N/A $34.32B $18.09B $16.17B
2023-12-31 $1.04B $N/A $34.06B $17.33B $16.61B
2022-12-31 $684.00M $N/A $34.82B $18.36B $16.33B
2021-12-31 $414.00M $N/A $34.45B $7.97B $26.36B
2020-12-31 $334.00M $N/A $34.13B $7.91B $26.11B
2019-12-31 $340.00M $N/A $35.71B $8.30B $27.32B

Watchlist

0

No stocks in watchlist